Success in value-based care (VBC) is contingent on driving measured improvements in chronic disease management in conditions such as Diabetes.
According to the American Diabetes Association (ADA), the estimated cost of diagnosed diabetes in the United States was $327 billion, and affects more than 37 million Americans.
Research shows that the implementation of comprehensive diabetes management programs that emphasize early identification, lifestyle interventions, and patient education can significantly reduce preventable hospitalizations and long-term healthcare costs related to diabetes complications.
Diagnostic Robotics’ Intelligent Care Journeys empowers health plans and risk-bearing providers with actionable insights, leveraging vast external data to deliver personalized next steps for every patient.
Reduce Diabetes Care Costs with Early Identification & Treatment
$888
PMPM savings
For a large national health plan’s diabetes program deployed with their value-based care providers
Proactive intervention stops preventable diabetes related hospitalizations and care cost escalations
67 years old, FemaleThe model identified a patient displaying non-adherence to diabetic medication and follow-up appointments related to his condition. Coupled with the recent diagnosis of diabetic neuropathy and tinea pedis, as well as an escalating frequency of emergency department visits, these factors were collectively detected to pose a significant risk for preventable diabetes-related hospitalizations
Lower costs by preventing diabetes exacerbation
Understand why your patients are at risk and recommend next steps for care based on the main risk factors based on their impact on future risk and costs
Book a demo
Tired of handling calls and messages?
Tell us which tasks you need to automate, and we'll show you how Maxine can save you time and cut costs.
Thank you!
Lorem ipsum about this text that we will decide later on.
